CT‐based non‐invasive identification of the most common gene mutation status in patients with non‐small cell lung cancer

Author:

Chen Zongjian1,Gao Si2,Ding Changwei3,Luo Ting4,Xu Jiaqi1,Xu Shuang5,Li Shu1

Affiliation:

1. School of Health Management China Medical University Shenyang Liaoning China

2. Department of Radiology The First Affiliated Hospital of China Medical University Liaoning Shenyang China

3. Department of Radiology Shengjing Hospital of China Medical University Shenyang Liaoning China

4. Department of Radiology Liaoning Cancer Hospital & Institute Shenyang Liaoning China

5. Library of China Medical University Shenyang Liaoning China

Abstract

AbstractBackgroundEpidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) are mutually exclusive, and they are two important genes that are most prone to mutation in patients with non‐small cell lung cancer.PurposeThis retrospective study investigated the ability of radiomics to predict the mutation status of EGFR and KRAS in patients with non‐small cell lung cancer (NSCLC) and guide precision medicine.MethodsComputed tomography images of 1045 NSCLC patients from five different institutions were collected, and 1204 imaging features were extracted. In the training set (EGFR: 678, KRAS: 246), Max‐Relevance and Min‐Redundancy and least absolute shrinkage and selection operator logistic regression were used to screen radiomics features. The combination of selected radiomics features and clinical factors was used to establish the combined models in identifying EGFR and KRAS mutation status, respectively, through stepwise logistic regression. Then, on two independent external validation sets (EGFR: 203/164, KRAS: 123/95), the performance of each model was evaluated separately, and then the overall performance of predicting the two mutation states was calculated.ResultsIn the EGFR and KRAS groups, radiomics signatures comprised 14 and 10 radiomics features, respectively. They were mutually exclusive between the tumors with positive EGFR mutation and those with positive KRAS mutation in imaging phenotype. For the EGFR group, the area under the curve (AUC) of the combined model in the two validation sets was 0.871 (95% CI: 0.821–0.926) and 0.861 (95% CI: 0.802–0.911), respectively, whereas the AUC of the combined model in the two validation sets was 0.798 (95% CI: 0.739–0.850) and 0.778 (95% CI: 0.735–0.821), respectively, for the KRAS group. Considering both EGFR and KRAS, the overall precision, recall, and F1‐score of the combined model in the two validation sets were 0.704, 0.844, and 0.768, as well as 0.754, 0.693, and 0.722, respectively.ConclusionsOur study demonstrates the potential of radiomics in the non‐invasive identification of EGFR and KRAS mutation status, which may guide patients with non‐small cell lung cancer to choose the most appropriate personalized treatment. This method can be used when biopsy will bring unacceptable risk to patients with NSCLC.

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3